AFP and hepatocellular carcinoma: Increasing evidence demonstrates that additional risks, such as AFP, microvascular invasion, or response to TACE, independently affect post-transplant survival or HCC recurrence in addition to conventionally accepted factors, such as tumour size, number and major vascular invasion12, 13, 14.